INS and obesity disorder: Obesity is a well-known risk factor for T2DM progression, and obesity-induced glucolipotoxicity (i.e., hyperglycemia and hyperlipidemia) inflicts oxidative stress, thus leading to impaired islet glucose-stimulated insulin secretion (GSIS) and apoptosis [3].